Analysis Nomura Micro Science Co., Ltd. (6254)
6/3/2024
Analysis of Nomura Micro Science Co., Ltd. (6254)
Nomura Micro Science Co., Ltd. (symbol: 6254) has been showing some fluctuations in its stock price recently.On June 3, 2024, the stock closed at 4625.00, with an RSI indicator of 39.76, indicating a slightly oversold condition. The MACD indicator was -174.04, showing a bearish trend. The Moving Average (MA) indicator was 5098.00, below the closing price, suggesting a bearish signal.
Looking at the historical data, we can see that the stock has been experiencing some volatility in the past few days. The RSI values have been fluctuating around the 40-50 range, indicating a neutral to slightly bearish sentiment. The MACD values have also been negative, showing a bearish trend.
Overall, Nomura Micro Science Co., Ltd. seems to be facing some selling pressure based on the technical indicators. Traders and investors may want to closely monitor the stock for any potential trend reversal or further downside movement.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics.
Overall, the data provides a comprehensive overview of the company's financial performance, stock statistics, valuation metrics, stock price trends, and dividends and splits information.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating stable pricing and cost management.
3. Despite fluctuations in net income, there is an overall positive trend in profitability.
4. Earnings per share (EPS) have shown some variation but have generally been on an upward trajectory.
5. Operating income and EBITDA have also been increasing, reflecting operational efficiency and growth.
6. The company has been able to manage its operating expenses effectively, as seen in the stable operating income.
7. The company's tax management strategy appears to be efficient, with income tax expenses in line with the increase in revenue.
8. Overall, the financial performance of the company seems to be strong and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. Provision for risks and charges has been relatively stable over the years.
9. Common stock and retained earnings are major components of shareholders' equity.
10. The company has been investing in leases, land, and improvements consistently.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant fluctuations, with large amounts being spent on common stock repurchase and debt issuance/payment.
4. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
5. The end cash position has been relatively stable, with some fluctuations due to the company's financial activities.
6. Interest paid has increased over the years, which could be a result of higher debt levels.
7. Income tax paid has also fluctuated, possibly due to changes in profitability and tax regulations.
8. Stock-based compensation has been a significant expense for the company, impacting its cash flow.
9. The company has been managing its cash flow well, as evidenced by its ability to maintain a healthy cash position despite fluctuations in other financial activities.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, showing a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a generally positive outlook for the company, with expected growth in both quarterly and annual sales over the coming quarters and years.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: For the current year, the estimated growth rate is 7.6%.
4. Next Year: The growth rate is expected to increase to 9.7% for the next year.
5. Past 5 Years (per annum): Over the past 5 years, the company has shown a growth rate of approximately 20.1% per annum.
6. Next 5 Years (per annum): Looking ahead, analysts project a growth rate of around 9.7% per annum for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rate expected in the upcoming periods compared to the current and past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of estimates, from a low of $164 to a high of $275, indicating some uncertainty in the predictions.
MACD of 6254
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
